Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison McGeer

Showing results (351-360 of 396) with videos related to

Pageof 40
Sort By:
Vaccine|September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Journal of Proteome Research|February 10, 2022
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19Yassene Mohammed, David R Goodlett, Matthew P Cheng, et al.
Open Forum Infectious Diseases|February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research NetworkHenrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Mucosal Immunology|January 26, 2024
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunitySabryna Nantel, Salma Sheikh-Mohamed, Gary Y C Chao, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Journal of Proteome Research|December 4, 2023
Proteomic Evolution from Acute to Post-COVID-19 ConditionsYassene Mohammed, Karen Tran, Chris Carlsten, et al.
Critical Care Explorations|May 30, 2025
Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired PneumoniaGeorge S Chen, Terry Lee, Jennifer L Y Tsang, et al.
Microbiology Spectrum|November 17, 2021
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization AssaysEmelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
The Journal of Infectious Diseases|September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeopleMelissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
Journal of Innate Immunity|December 3, 2024
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19Greg Haljan, Terry Lee, Anne McCarthy, et al.
Pageof 40

Showing results (351-360 of 396) with videos related to

Sort By:
Pageof 40
Vaccine|September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Journal of Proteome Research|February 10, 2022
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19Yassene Mohammed, David R Goodlett, Matthew P Cheng, et al.
Open Forum Infectious Diseases|February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research NetworkHenrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Mucosal Immunology|January 26, 2024
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunitySabryna Nantel, Salma Sheikh-Mohamed, Gary Y C Chao, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Journal of Proteome Research|December 4, 2023
Proteomic Evolution from Acute to Post-COVID-19 ConditionsYassene Mohammed, Karen Tran, Chris Carlsten, et al.
Critical Care Explorations|May 30, 2025
Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired PneumoniaGeorge S Chen, Terry Lee, Jennifer L Y Tsang, et al.
Microbiology Spectrum|November 17, 2021
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization AssaysEmelissa J Valcourt, Kathy Manguiat, Alyssia Robinson, et al.
The Journal of Infectious Diseases|September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeopleMelissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
Journal of Innate Immunity|December 3, 2024
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19Greg Haljan, Terry Lee, Anne McCarthy, et al.
Pageof 40